In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cephalon buys two CTI divisions

Executive Summary

In connection with its separate purchase of Cell Therapeutics Inc.'s CTI Technologies Inc.’s leukemia drug Trisenox (arsenic trioxide), Cephalon Inc. (therapeutics for neurological diseases and cancer) has also agreed to acquire two Cell Therapeutics’ wholly-owned subsidiaries: PolaRx Biopharmaceuticals Inc. and Cell Therapeutics (UK) Ltd.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Full Acquisition
    • Includes Contract
    • Intra-Biotech Deal

Related Companies